Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

		Phase:		Phase 3

		Treatment ID#:		1924

		Age Group:		Adults Only

		Min Karnofsky Score:		70: Cares for self, unable to perform normal activity or to do active work

		Conditions:		Prior Surgery is Allowed Prior Radiation is Sometimes Allowed Prior Chemotherapy is Sometimes Allowed

		Last Updated:		09/30/2009

		Tumor Types:		Glioblastoma Multiforme


		Comments:		See http://virtualtrials.com/news3.cfm?item=4336 for results of a small pilot study of this treatment.

		Treatment Type:		Chemotherapy Less-Toxics

		Contact:		Herbert H. Engelhard M.D., Ph.D., F.A.C.S. Associate Professor / Department of Neurosurgery U. Of Illinois College of Medicine Contact: Karriem Watson MC 799, 912 South Wood St. Chicago, IL 60612 Phone: 800-597-5970 Fax: (312) 996-9018 E-mail: hhengel@uic.edu Website:

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By